The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Abstract
CONTEXT: Prostate-specific antigen screening has led to an increase in the diagnosis and treatment of localized prostate cancer. However, the role of active treatment of low- and intermediate-risk disease in elderly men is controversial. OBJECTIVE: To estimate the association between treatment (with radiation therapy or radical prostatectomy) compared with observation and overall survival in men with low- and intermediate-risk prostate cancer. DESIGN AND SETTING: Observational US cohort from Surveillance, Epidemiology, and End Results Medicare data. PATIENTS: At total of 44,630 men aged 65 to 80 years who were diagnosed between 1991 and 1999 with organ-confined, well- or moderately differentiated prostate cancer and who had survived more than a year past diagnosis. Patients were followed up until death or study end (December 31, 2002). Patients were classified as having received treatment (n=32,022) if they had claims for radical prostatectomy or radiation therapy during the first 6 months after diagnosis. They were classified as having received observation (n=12,608) if they did not have claims for radical prostatectomy, radiation, or hormonal therapy. Patients who received only hormonal therapy were excluded. MAIN OUTCOME MEASURE: Overall survival. RESULTS: At the end of the 12-year study period, 4663 men (37%) in the observational group and 7639 men (23.8%) in the treatment group had died. The treatment group had longer 5- and 10-year survival than the observation group. After using propensity scores to adjust for potential confounders (tumor characteristics, demographics, and comorbidities), there was a statistically significant survival advantage associated with treatment (hazard ratio, 0.69; 95% confidence interval, 0.66-0.72). A benefit associated with treatment was seen in all subgroups examined, including older men (aged 75-80 years at diagnosis), black men, and men with low-risk disease. CONCLUSIONS: This study suggests a survival advantage is associated with active treatment for low- and intermediate-risk prostate cancer in elderly men aged 65 to 80 years. Because observational data cannot completely adjust for potential selection bias and confounding, these results must be validated in randomized controlled trials of alternative management strategies in elderly men with localized prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
Rosenbaum, P. R., & Rubin, D. B. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10478078 · Cited by 3,082
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Pound, C. R. (1999) · JAMA · doi:10.1001/jama.281.17.1591 · Cited by 3,071
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Development of a comorbidity index using physician claims data
Klabunde, C. N., Potosky, A. L., Legler, J. M., & Warren, J. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00256-0 · Cited by 1,845
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,626
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,187
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043739 · Cited by 1,111
The Effectiveness of Adjustment by Subclassification in Removing Bias in Observational Studies
Cochran, W. G. (1968) · Biometrics · doi:10.2307/2528036 · Cited by 961
Etzioni, R. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.981 · Cited by 949
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Mohler, J., Bahnson, R. R., Boston, B., Busby, J. E., D'Amico, A., Eastham, J. A., Enke, C. A., George, D., Horwitz, E. M., Huben, R. P., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0012 · Cited by 897
A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Assessing the sensitivity of regression results to unmeasured confounders in observational studies
Lin, D. Y., Psaty, B. M., & Kronmal, R. A. (1998) · Biometrics · doi:10.2307/2533848 · Cited by 742
Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Albertsen, P. C. (1998) · JAMA · doi:10.1001/jama.280.11.975 · Cited by 717
Radiation Therapy for Clinically Localized Prostate Cancer: A Multi-institutional Pooled Analysis
Shipley, W. U., Thames, H. D., Sandler, H. M., Hanks, G. E., Zietman, A. L., Perez, C. A., Kuban, D. A., Hancock, S. L., & Smith, C. D. (1999) · JAMA · doi:10.1001/jama.281.17.1598 · Cited by 440
Myelinolysis after Correction of Hyponatremia
Laureno, R., & Karp, B. I. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-1-199701010-00008 · Cited by 419
Population-based study of long-term survival in patients with clinically localised prostate cancer
Lu-Yao, G. L., & Yao, S.-L. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09380-4 · Cited by 416
Giant Cell Arteritis: Validity and Reliability of Various Diagnostic Criteria
HAYREH, S. S., PODHAJSKY, P. A., RAMAN, R., & ZIMMERMAN, B. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70123-0 · Cited by 412
Problems With Proper Completion and Accuracy of the Cause-of-Death Statement
Sehdev, A. E. S., & Hutchins, G. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.2.277 · Cited by 342
Chang, K. P., Center, J. R., Nguyen, T. V., & Eisman, J. A. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040109 · Cited by 251
Changes in Elderly Disability Rates and the Implications for Health Care Utilization and Cost
SPILLMAN, B. C. (2004) · The Milbank Quarterly · doi:10.1111/j.0887-378x.2004.00305.x · Cited by 228
Prostate Cancer Practice Patterns and Quality of Life: the Prostate Cancer Outcomes Study
Potosky, A. L., Harlan, L. C., Stanford, J. L., Gilliland, F. D., Hamilton, A. S., Albertsen, P. C., Eley, J. W., Liff, J. M., Deapen, D., Stephenson, R. A., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.20.1719 · Cited by 215
Alibhai, S. M. H., Leach, M., Tomlinson, G., Krahn, M. D., Fleshner, N., Holowaty, E., & Naglie, G. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji313 · Cited by 204
Multivariate Matching and Bias Reduction in the Surgical Outcomes Study
Silber, J. H., Rosenbaum, P. R., Trudeau, M. E., Even-Shoshan, O., Chen, W., Zhang, X., & Mosher, R. E. (2001) · Medical Care · doi:10.1097/00005650-200110000-00003 · Cited by 170
Does This Patient With Headache Have a Migraine or Need Neuroimaging?
Detsky, M. E., McDonald, D. R., Baerlocher, M. O., Tomlinson, G. A., McCrory, D. C., & Booth, C. M. (2006) · JAMA · doi:10.1001/jama.296.10.1274 · Cited by 163
Hoffman, R. M., Hunt, W. C., Gilliland, F. D., Stephenson, R. A., & Potosky, A. L. (2003) · Cancer · doi:10.1002/cncr.11233 · Cited by 162
Molla, A. M., Rhman, M., Sarker, S., Sack, D. A., & Molla, A. M. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80863-3 · Cited by 123
Critical evaluation of hormonal therapy for carcinoma of the prostate
Chodak, G. W., Keane, T. E., & Klotz, L. H. (2002) · Urology · doi:10.1016/s0090-4295(02)01677-1 · Cited by 87
Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study
Mitra, N., & Heitjan, D. F. (2006) · Statistics in Medicine · doi:10.1002/sim.2606 · Cited by 61
Self-citationHoffman, R. M., Stone, S. N., Espey, D. K., & Potosky, A. L. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-27 · Cited by 44
Beissner, R. S., Stricker, J. B., Speights, V. O., Coffield, K. S., Spiekerman, A. M., & Riggs, M. W. (2002) · Urology · doi:10.1016/s0090-4295(02)01531-5 · Cited by 24
Cited by
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Wilt, T. J., MacDonald, R., Rutks, I., Shamliyan, T. A., Taylor, B. C., & Kane, R. L. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00209 · Cited by 597
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou, R., Croswell, J. M., Dana, T., Bougatsos, C., Blazina, I., Fu, R., Gleitsmann, K., Koenig, H. C., Lam, C., Maltz, A., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00375 · Cited by 573
Carter, H. B., Ferrucci, L., Kettermann, A., Landis, P., Wright, E. J., Epstein, J. I., Trock, B. J., & Metter, E. J. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj410 · Cited by 556
Fenton, J. J., Weyrich, M. S., Durbin, S., Liu, Y., Bang, H., & Melnikow, J. (2018) · JAMA · doi:10.1001/jama.2018.3712 · Cited by 555
Metadata
- Authors
- Wong, Y.-N., Mitra, N., Hudes, G., Localio, R., Schwartz, J. S., Wan, F., Montagnet, C., & Armstrong, K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-12-13
- Volume
- 296
- Issue
- 22
- Pages
- 2683
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2031048427
- Cited by
- 305
- References
- 33
- FWCI
- 26.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.